Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 14, 2013 - Issue 3
Submit an article Journal homepage
1,348
Views
36
CrossRef citations to date
0
Altmetric
Reviews

Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions

Pilar Brito-ZerónIDIBAPS, ICMiD, Hospital Clínic, Department of Autoimmune Diseases, Laboratory of Autoimmune Diseases Josep Font, Sjögren Syndrome Research Group (AGAUR), C/Villarroel, 170, 08036-Barcelona, Spain+34 93 2275774; +34 93 2271707; [email protected]
,
Antoni Sisó-AlmirallIDIBAPS, Primary Care Center Les Corts, CAPSE, Primary Care Research Group, Barcelona, Spain
,
Albert BovéIDIBAPS, ICMiD, Hospital Clínic, Department of Autoimmune Diseases, Laboratory of Autoimmune Diseases Josep Font, Sjögren Syndrome Research Group (AGAUR), C/Villarroel, 170, 08036-Barcelona, Spain+34 93 2275774; +34 93 2271707; [email protected]
,
Belchin A KostovIDIBAPS, Primary Care Center Les Corts, CAPSE, Primary Care Research Group, Barcelona, Spain
&
Manuel Ramos-CasalsIDIBAPS, ICMiD, Hospital Clínic, Department of Autoimmune Diseases, Laboratory of Autoimmune Diseases Josep Font, Sjögren Syndrome Research Group (AGAUR), C/Villarroel, 170, 08036-Barcelona, Spain+34 93 2275774; +34 93 2271707; [email protected]
Pages 279-289 | Published online: 25 Jan 2013

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mingjun Gao, Lin Zhao, Ran Liang, Qing Zhu, Qi Zhao & Xiaodan Kong. (2022) Evaluation of the Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops (II) in the Treatment of Dry Eye Associated with Primary Sjögren’s Syndrome. Ocular Immunology and Inflammation 0:0, pages 1-7.
Read now
Soledad Retamozo, Antoni Sisó-Almirall, Alejandra Flores-Chávez, Manuel Ramos-Casals & Pilar Brito-Zerón. (2021) An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development. Expert Opinion on Pharmacotherapy 22:17, pages 2359-2371.
Read now

Articles from other publishers (34)

Cuicui Fu, Xiaoyun Qin, Wenlong Shao, Jin Zhang, Ting Zhang, Jiaqi Yang, Chong Ding, Yeqing Song, Xuejun Ge, Gang Wu, Floris J. Bikker & Nan Jiang. (2023) Carbon quantum dots as immune modulatory therapy in a Sjögren's syndrome mouse model. Oral Diseases.
Crossref
Fabiola Atzeni, Francesco Gozza, Giacomo Cafaro, Carlo Perricone & Elena Bartoloni. (2022) Cardiovascular Involvement in Sjögren’s Syndrome. Frontiers in Immunology 13.
Crossref
Najla Dar-Odeh, Shadia Elsayed, Hamzah Babkair, Shaden Abu-Hammad, Nebras Althagafi, Rayan Bahabri, Yasmin Salah Eldeen, Wejdan Aljohani & Osama Abu-Hammad. (2021) What the dental practitioner needs to know about pharmaco-therapeutic modalities of COVID-19 treatment: A review. Journal of Dental Sciences 16:3, pages 806-816.
Crossref
Robert I. Fox, Carla M. Fox, Jacques Eric Gottenberg & Thomas Dörner. (2021) Treatment of Sjögren’s syndrome: current therapy and future directions. Rheumatology 60:5, pages 2066-2074.
Crossref
Gricelis P. Martinez, Mercedes E. Zabaleta, Camilo Di Giulio, Jaime E. Charris & Michael R. Mijares. (2020) The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases. Current Pharmaceutical Design 26:35, pages 4467-4485.
Crossref
Najla Dar-Odeh, Hamzah Babkair, Shaden Abu-Hammad, Sary Borzangy, Abdalla Abu-Hammad & Osama Abu-Hammad. (2020) COVID-19: Present and Future Challenges for Dental Practice. International Journal of Environmental Research and Public Health 17:9, pages 3151.
Crossref
Maria Maślińska. 2019. Chronic Autoimmune Epithelitis - Sjogren's Syndrome and Other Autoimmune Diseases of the Exocrine Glands. Chronic Autoimmune Epithelitis - Sjogren's Syndrome and Other Autoimmune Diseases of the Exocrine Glands.
Siri Beier Jensen, Arjan Vissink & Norman Firth. 2019. Contemporary Oral Medicine. Contemporary Oral Medicine 1437 1521 .
Jiaxin Yuan, Li Gong, Hongliang Wu, Qi Chen, Jiahui Wang, Weiyi Chen, Xiaotong Wang & Chao Ren. (2018) Case report of primary Sjögren Syndrome with simple trigeminal lesion as initial symptom. Journal of Neuroimmunology 324, pages 126-128.
Crossref
Soledad Retamozo, Alejandra Flores-Chavez, Marta Consuegra-Fernández, Francisco Lozano, Manuel Ramos-Casals & Pilar Brito-Zerón. (2018) Cytokines as therapeutic targets in primary Sjögren syndrome. Pharmacology & Therapeutics 184, pages 81-97.
Crossref
Siri Beier Jensen, Arjan Vissink & Norman Firth. 2018. Contemporary Oral Medicine. Contemporary Oral Medicine 1 85 .
J. Demarchi, S. Papasidero, M. A. Medina, D. Klajn, R. Chaparro del Moral, O. Rillo, V. Martiré, G. Crespo, A. Secco, A. Catalan Pellet, C. Amitrano, C. Crow, C. Asnal, P. Pucci, F. Caeiro, N. Benzanquen, J. P. Pirola, M. Mayer, F. Zazzetti, S. Velez, J. Barreira, N. Tamborenea, L. Santiago & L. Raiti. (2017) Primary Sjögren’s syndrome: Extraglandular manifestations and hydroxychloroquine therapy. Clinical Rheumatology 36:11, pages 2455-2460.
Crossref
Hyun Jung Kim, Kyoung Hoon Kim, Hoo Jae Hann, Seungjin Han, Yuri Kim, Sang Hyuk Lee, Dong Sook Kim & Hyeong Sik Ahn. (2017) Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren’s syndrome in Korea: A nationwide, population-based study. Seminars in Arthritis and Rheumatism 47:2, pages 222-227.
Crossref
Iona Thorne & Nurhan Sutcliffe. (2017) Sjögren's syndrome. British Journal of Hospital Medicine 78:8, pages 438-442.
Crossref
Takanori Fujimura, Takashi Fujimoto, Asako Itaya-Hironaka, Tomoko Miyaoka, Kiyomi Yoshimoto, Sumiyo Sakuramoto-Tsuchida, Akiyo Yamauchi, Maiko Takeda, Hiroki Tsujinaka, Yasuhito Tanaka & Shin Takasawa. (2016) Significance of Interleukin-6/STAT Pathway for the Gene Expression of REG Iα, a New Autoantigen in Sjögren’s Syndrome Patients, in Salivary Duct Epithelial Cells. Clinical Reviews in Allergy & Immunology 52:3, pages 351-363.
Crossref
Tomohiko Fukuda, Katsutoshi Oda, Osamu Wada-Hiraike, Kenbun Sone, Kanako Inaba, Yuji Ikeda, Chinami Makii, Aki Miyasaka, Tomoko Kashiyama, Michihiro Tanikawa, Takahide Arimoto, Tetsu Yano, Kei Kawana, Yutaka Osuga & Tomoyuki Fujii. (2016) Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells. Oncology Letters 12:4, pages 2560-2566.
Crossref
Claudia Kedor, Jan Zernicke, Anja Hagemann, Lorena Martinez Gamboa, Johanna Callhoff, Gerd-Rüdiger Burmester & Eugen Feist. (2016) A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren’s syndrome. Clinical Rheumatology 35:9, pages 2203-2210.
Crossref
Brith Bergum, Catalin Koro, Nicolas Delaleu, Magne Solheim, Annelie Hellvard, Veronika Binder, Roland Jonsson, Valeria Valim, Daniel S Hammenfors, Malin V Jonsson & Piotr Mydel. (2016) Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity. Annals of the Rheumatic Diseases 75:8, pages 1494-1500.
Crossref
A Alunno, F Carubbi, O Bistoni, S Caterbi, E Bartoloni, P Di Benedetto, P Cipriani, R Giacomelli & R Gerli. (2016) Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study. Clinical and Experimental Immunology 184:3, pages 284-292.
Crossref
Tatiana Kelly da Silva Fidalgo, Carla Nogueira, Marcia Rejane Thomas Canabarro Andrade, Andrea Graciene Lopez Ramos Valente & Patricia Nivoloni Tannure. (2016) Oral Rehabilitation and Management for Secondary Sjögren’s Syndrome in a Child. Case Reports in Dentistry 2016, pages 1-5.
Crossref
F. Carubbi, P. Cipriani & R. Giacomelli. 2016. Sjogren's Syndrome. Sjogren's Syndrome 273 289 .
Soledad Retamozo, Pilar Brito-Zerón, Hoda Gheitasi, Verónica Saurit & Manuel Ramos-Casals. 2016. Connective Tissue Disease. Connective Tissue Disease 383 398 .
Baodong Qin, Jiaqi Wang, Zaixing Yang, Min Yang, Ning Ma, Fenglou Huang & Renqian Zhong. (2015) Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis. Annals of the Rheumatic Diseases 74:11, pages 1983-1989.
Crossref
Rhys Evans, Anselm Zdebik, Coziana Ciurtin & Stephen B. Walsh. (2015) Renal involvement in primary Sjögren’s syndrome. Rheumatology 54:9, pages 1541-1548.
Crossref
Francesco Carubbi, Alessia Alunno, Paola Cipriani, Onorina Berardicurti, Piero Ruscitti, Vasiliki Liakouli, Francesco Ciccia, Giovanni Triolo, Roberto Gerli & Roberto Giacomelli. (2015) Use of Rituximab in the Management of Sjögren’s Syndrome. Current Treatment Options in Rheumatology 1:3, pages 277-291.
Crossref
H. Gheitasi, B. Kostov, R. Solans, G. Fraile, C. Suárez-Cuervo, A. Casanovas, F.J. Rascón, R. Qanneta, R. Pérez-Alvarez, M. Ripoll, M. Akasbi, B. Pinilla, J.A. Bosch, J. Nava-Mateos, B. Díaz-López, M.L. Morera-Morales, S. Retamozo, M. Ramos-Casals & P. Brito-Zerón. (2015) How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patients. International Immunopharmacology 27:2, pages 194-199.
Crossref
Tomohiko Fukuda, Katsutoshi Oda, Osamu Wada-Hiraike, Kenbun Sone, Kanako Inaba, Yuji Ikeda, Aki Miyasaka, Tomoko Kashiyama, Michihiro Tanikawa, Takahide Arimoto, Hiroyuki Kuramoto, Tetsu Yano, Kei Kawana, Yutaka Osuga & Tomoyuki Fujii. (2015) The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition. Gynecologic Oncology 137:3, pages 538-545.
Crossref
Lucas T. Woods, Jean M. Camden, Farid G. El-Sayed, Mahmoud G. Khalafalla, Michael J. Petris, Laurie Erb & Gary A. Weisman. (2015) Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation. PLOS ONE 10:5, pages e0123641.
Crossref
Sabrina Lisi, Margherita Sisto, Massimo D’Amore & Dario Domenico Lofrumento. (2015) Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren’s syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway. International Immunology 27:4, pages 183-194.
Crossref
Alessia Alunno, Francesco Carubbi, Onelia Bistoni, Sara Caterbi, Elena Bartoloni, Giulia Mirabelli, Francesca Cannarile, Paola Cipriani, Roberto Giacomelli & Roberto Gerli. (2015) T Regulatory and T Helper 17 Cells in Primary Sjögren’s Syndrome: Facts and Perspectives. Mediators of Inflammation 2015, pages 1-10.
Crossref
F Carubbi, A Alunno, P Cipriani, E Bartoloni, F Ciccia, G Triolo, R Gerli & R Giacomelli. (2014) Rituximab in primary Sjögren's syndrome: a ten-year journey. Lupus 23:13, pages 1337-1349.
Crossref
Tor Paaske Utheim. 2014. The Value of BCG and TNF in Autoimmunity. The Value of BCG and TNF in Autoimmunity 105 125 .
A. Vissink. 2014. Speeksel en speekselklieren. Speeksel en speekselklieren 227 243 .
Pilar Brito-Zerón, Antoni Sisó-Almirall, Belchin Kostov, Xavier Bosch, Athanasios G. Tzioufas & Manuel Ramos-Casals. 2014. Drugs Targeting B-Cells in Autoimmune Diseases. Drugs Targeting B-Cells in Autoimmune Diseases 111 138 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.